Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Coagulation Disorder: later-stage trial registry

1 of 2 indexed Coagulation Disorder trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Coagulation Disorder: 2 US clinical trials tracked, 1 recruiting.

Coagulation Disorder is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is HemoSonics, running 1 of these trials.

Enrollment posture brief

Registry condition coagulation-disorder

OPEN 1 | RECR 50% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Coagulation Disorder (this)50%
Open-enrollment share among volume-matched conditions near Coagulation Disorder

Coagulation Disorder lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Coagulation Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Coagulation Disorder is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

HemoSonics 1 trials
Takeda 1 trials

Named interventions

Most-linked intervention names on Coagulation Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Quantra System Diagnostic test
1 trials
SOC 4f-pcc Drug
1 trials
TAK-330 Drug
1 trials

US sites by state

Facility locations filed on Coagulation Disorder trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Virginia 1 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Oklahoma 1 trials
Ohio 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Coagulation Disorder page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Coagulation Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • HemoSonics sponsors the most Coagulation Disorder trials on record, review their full trial history before evaluating a specific study. See HemoSonics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coagulation Disorder condition card totals 2 registered trials; most-linked intervention Quantra System; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.